Charles River Partners with Autobahn Labs to Accelerate Academic Drug Discovery and Development

Agreement establishes Charles River as the preferred partner for Autobahn Labs, leveraging drug discovery and development capabilities to acceler...

July 25, 2024 | Thursday | News
Rona Therapeutics Secures $35 Million Series A+ Financing Led by LongRiver Investments

Rona Therapeutics, a clinical stage pioneering platform company in nucleic acid drug research and development, today announced the completion of $35 Mill...

July 19, 2024 | Friday | News
CordenPharma Announces Record €900M Investment to Expand Peptide Platform in US and Europe

CordenPharma is making a record investment of ~€900m over the next 3 years in expanding its peptide platform, both at its Colorado, US site and in...

July 16, 2024 | Tuesday | News
AusperBio Therapeutics Secures $37 Million Series A Financing

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to ...

July 15, 2024 | Monday | News
Apriori Bio Secures $1.1 Million from CEPI to Enhance AI-Driven Vaccine Platform Against Evolving Viruses

Biotechnology company Apriori Bio has been awarded US $1.1 million from CEPI to advance its biology-informed artificial intelligence platform Octavi...

July 09, 2024 | Tuesday | News
Adcytherix Launches with €30 Million Seed Funding to Pioneer Next-Generation Antibody-Drug Conjugates for Cancer Treatment

Vision is to establish a leading ADC developer to treat high unmet need diseases such as cancer. Founded by the team that founded and sold Emergence T...

June 11, 2024 | Tuesday | News
ArkeaBio™ Secures $26.5 Million Series A Funding to Develop Paradigm-Shifting Livestock Methane Reduction Vaccine

ArkeaBio™, a leading ag-biotech start-up developing a vaccine to reduce livestock methane emissions, announced the close of a $26.5 million Series A ...

May 09, 2024 | Thursday | News
German Chancellor Olaf Scholz Lauds Merck's €300 Million Investment in New Darmstadt Research Center, Bolstering Germany as a Top Biopharmaceutical Hub

German Chancellor Olaf Scholz emphasizes significance for Germany as research location at cornerstone laying ceremony Research center to accelerate biop...

April 26, 2024 | Friday | News
Abzena's $5 Million Investment Boosts Bristol Facility's Bioconjugation Capabilities and Enhances Operational Efficiency

 The $5 million investment in expanded laboratory space, new equipment, and facility upgrades, builds upon the site’s existing bioconjugation ca...

March 28, 2024 | Thursday | News
Samsung Ventures Backs BrickBio to Pave the Way for Next-Generation Therapies

Samsung Ventures, a key player in the life sciences sector, has made a strategic investment in BrickBio, Inc., a preclinical-stage biopharmaceutical compan...

March 19, 2024 | Tuesday | News
Kenai Therapeutics Secures $82 Million Series A Funding to Advance Parkinson's Disease Treatment Trials

  – Proceeds will be used to complete clinical demonstration trials of the lead candidate drug RNDP-001 for the treatment of Parkinson's di...

March 11, 2024 | Monday | News
AstraZeneca plans £650 million investment in UK

AstraZeneca intends to invest £450 million to research, develop and manufacture vaccines in Speke, Liverpool, a facility which will be operationall...

March 07, 2024 | Thursday | News
BiomX Acquires Adaptive Phage Therapeutics, Secures $50M for Clinical Trials

  Immediately after the effective time of the Acquisition, and before giving effect to the concurrent private placement the former stockholders of Bi...

March 06, 2024 | Wednesday | News
Willow Biosciences Secures Second Strategic Investment from Kalsec

Willow Biosciences, a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable functional ing...

March 04, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close